Mattias Perjos appointed President and CEO of Getinge Group

2016.11.03

The Board of Getinge AB is today announcing the appointment of Mattias Perjos as President and CEO of Getinge. Mattias currently holds the role as CEO of Coesia Industrial Process Solutions (IPS) as well as Managing Director of Coesia International. Mattias will assume his position on
May 1, 2017 at the latest.
 

”I am very pleased to welcome Mattias Perjos to Getinge. He has an extensive industrial background and international experience that will be a great asset to Getinge as we meet our challenges and continue to build the company for the future. In addition, he has an impressive track record of consistently achieving improved business results” says Carl Bennet, Chairman of the Group.    

Mattias Perjos joins Getinge from the Coesia Group, a privately owned Italian group of companies, where he holds the position as CEO of the IPS Division and a member of Group management since 2012. In addition to his role as CEO, Mattias is Managing Director of Coesia International which includes the subsidiaries in China, Japan, South Korea, South-East Asia, India, the Americas, Russia, Africa and the Middle East. Coesia is a fast-growing company that produces high-tech machinery for the pharmaceutical, food and packaging industries. Group sales reached approximately SEK 15 billion in 2015, with 6,000 employees worldwide, of which the Coesia IPS Division and Coesia International account for two thirds of the revenue.  

Mattias began his career at Sandvik and shortly thereafter joined FlexLink, where he held a number of leading international positions between the years 1997 and 2012 including the role of CEO from 2006. During Mattias’ tenure as CEO, FlexLink was acquired by the Coesia group, and the company is now under his responsibility within the Coesia IPS Division. Mattias was born in 1972 and holds a Master of Science in Industrial Engineering and Management from Luleå University of Technology.  

“It is a great honour to be given the opportunity to lead Getinge Group towards the future. Getinge is a great  company and I have closely followed its performance over many years. I am aware that the company is undergoing an extensive transformation and I look forward to meeting the challenges and to building a strong Getinge together with its employees” says Mattias Perjos. 

Joacim Lindoff will continue in his role as Acting President and CEO until Mattias takes up his position. Thereafter, Joacim will be responsible for Patient & Post-Acute Care and will continue to be part of Getinge’s Executive Team. Should the Extra General Meeting approve the Board’s proposal on the distribution of Patient & Post-Acute Care, formerly Extended Care, the intention is to appoint Joacim President & CEO for the newly listed company. Further, the intention is that Johan Malmquist becomes the Chairman of the Board of the new company.  

”Joacim has done a very good job as Acting President and CEO for Getinge and I am very pleased that he will lead the newly listed company in the future”, says Carl Bennet. 

Mattias Perjos will assume his new position on May 1, 2017 at the latest.  

For further information, please contact: 

Kornelia Rasmussen                                                                   Lars Mattsson 
Executive Vice President, Communications Getinge Group       Head of Investor Relations Getinge Group  
Phone. +46 10-335 58 10                                                            Phone. +46 10-335 00 48 
Email: kornelia.rasmussen@getinge.com                                   Email: lars.mattsson@getinge.com 

Getinge Group is a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. Getinge’s unique customer offering mirrors the hospital’s organization and value chain, and the solutions are used before, during and after the patients’ hospital stay. Based on first-hand experience and close partnerships, Getinge provides innovative healthcare solutions that improve every-day life for people, today and tomorrow. 

This information is such that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on November 3, 2016 at 8.00 am CET. 

wkr0006.pdf